Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report

por Kikuchi, Fumi, Saheki, Takanobu, Imachi, Hitomi, Kobayashi, Toshihiro, Fukunaga, Kensaku, Ibata, Tomohiro, Sato, Seisuke, Ban, Natsuki, Lyu, Jingya, Japar, Salimah, Murao, Koji
Publicado 2021

Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto’s disease and diabetes mellitus: a case report

por Yonezaki, Kazuko, Kobayashi, Toshihiro, Imachi, Hitomi, Yoshimoto, Takuo, Kikuchi, Fumi, Fukunaga, Kensaku, Sato, Seisuke, Ibata, Tomohiro, Yamaji, Nao, Lyu, Jingya, Dong, Tao, Murao, Koji
Publicado 2018

Bilateral Adrenocortical Adenomas along with Virilization and Cushing's Syndrome

por Kobayashi, Toshihiro, Imachi, Hitomi, Sato, Seisuke, Ibata, Tomohiro, Fukunaga, Kensaku, Yoshimoto, Takuo, Kikuchi, Fumi, Yonezaki, Kazuko, Yamaji, Nao, Lyu, Jingya, Dong, Tao, Nagata, Hiromi, Kadota, Kyuichi, Kushida, Yoshio, Haba, Reiji, Murao, Koji
Publicado 2018

Thyroid stimulating hormone stimulates the expression of glucose transporter 2 via its receptor in pancreatic β cell line, INS-1 cells

por Lyu, Jingya, Imachi, Hitomi, Yoshimoto, Takuo, Fukunaga, Kensaku, Sato, Seisuke, Ibata, Tomohiro, Kobayashi, Toshihiro, Dong, Tao, Yonezaki, Kazuko, Yamaji, Nao, Kikuchi, Fumi, Iwama, Hisakazu, Ishikawa, Ryou, Haba, Reiji, Sugiyama, Yasunori, Zhang, Huanxiang, Murao, Koji
Publicado 2018